Training in Emerging Infectious Diseases

新发传染病培训

• 批准号: 8550938
• 负责人: Robert W. Doms
• 金额: $ 20.25万
• 依托单位: UNIVERSITY OF PENNSYLVANIA
• 依托单位国家: 美国
• 财政年份: 2003
• 资助国家: 美国
• 起止时间: 2003-08-01 至 2018-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8550938
• 关键词: Emerging Communicable Diseases; Training

DESCRIPTION (provided by applicant): This application represents the second competing renewal for our Training in Emerging Infectious Disease (EID) Training program based at the University of Pennsylvania that supports 3 predoctoral and 2 postdoctoral trainees per year. Of the more than 70 faculty whose primary affiliation is with the microbiology program, a select group of 12 faculty are trainers with this EID T32. All of the trainers have significant EID research programs, and 7 have been funded by the Middle Atlantic Regional Center of Excellence in Biodefense and Emerging Infectious Diseases. An active Executive Committee coupled with an experienced Internal Advisory Committee insures that this program retains a very tight focus on the study of emerging and re-emerging pathogens. As a result, trainers have been dropped from the program when their EID programs have faded while others have been added. This program has served to coalesce EID research training on our campus, with our trainers instituting a popular EID lecture course, a rigorous BSL3 training program, and a Certificate in Public Health Program. Our recent introduction of Individual Development Plans for our students and postdocs is making it possible for us to tailor our training activities to bes meet the needs of our trainees. Importantly, Penn continues to provide significant, direct support to training activities, including $7 million for our new ABSL3/BSL3 and via supporting predoctoral trainees for their first 21 months of graduate school. Thus, our T32 supports trainees only after they have completed all coursework and their prelim exams. Thus far, this T32 has supported 28 trainees, almost all for 2 years each, including 13 Ph.D. students, 4 M.D./Ph.D. students, 1 VMD/Ph.D. student and 10 Ph.D. postdoctoral fellows. Our 28 trainees have worked in the labs of 15 different trainers. Only one very recently added trainer has not had a trainee supported by this T32 program. Of the 28 current and past trainees, 15 are women, 13 are men, and 4 are minorities/disadvantaged (14%). Our retention rate is 93%, and those who have completed training and left Penn have obtained good positions (for the postdocs) and excellent postdoctoral positions at leading institutions, with most continuing to study emerging infectious agents. The accomplishments of our trainees coupled with their career progress since leaving Penn shows that our T32 program is indeed training promising young scientists to enter careers in Emerging Infectious Diseases.

描述（由申请人提供）：本申请是宾夕法尼亚大学新发传染病 (EID) 培训计划的第二次竞争更新，该计划每年支持 3 名博士前培训生和 2 名博士后培训生。在主要从事微生物学项目的 70 多名教职人员中，有 12 名教职人员经过精心挑选，担任 EID T32 的培训师。所有培训师都有重要的 EID 研究项目，其中 7 名培训师得到了中大西洋生物防御和新发传染病卓越区域中心的资助。活跃的执行委员会与经验丰富的内部咨询委员会相结合，确保该计划始终高度关注新出现和重新出现的病原体的研究。因此，当培训师的 EID 项目逐渐消失时，他们就会从该项目中删除，而其他培训师则被添加进来。该计划将我们校园内的 EID 研究培训结合起来，我们的培训师开设了受欢迎的 EID 讲座课程、严格的 BSL3 培训计划和公共卫生计划证书。我们最近为学生和博士后推出的个人发展计划使我们能够定制培训活动以满足学员的需求。重要的是，宾夕法尼亚大学继续为培训活动提供重要的直接支持，包括为我们新的 ABSL3/BSL3 提供 700 万美元，并支持博士前学员进入研究生院的前 21 个月。因此，我们的 T32 仅在学员完成所有课程和预备考试后才为他们提供支持。到目前为止，这台T32已经支持了28名学员，几乎都是每人两年，其中包括13名博士生。学生，4 名医学博士/博士学生，1 名 VMD/Ph.D。学生和10名博士。博士后研究员。我们的 28 名学员曾在 15 名不同培训师的实验室工作。只有一位最近添加的培训师没有受此 T32 计划支持的学员。在 28 名现任和过去的学员中，15 名是女性，13 名是男性，4 名是少数族裔/弱势群体 (14%)。我们的保留率为 93%，那些完成培训并离开宾夕法尼亚大学的人都在领先机构获得了良好的职位（博士后）和优秀的博士后职位，其中大多数人继续研究新出现的传染原。我们的学员所取得的成就以及他们离开宾夕法尼亚大学后的职业进步表明，我们的 T32 项目确实正在培训有前途的年轻科学家进入新发传染病领域的职业生涯。